IBT International Biotechnology Trust Plc

684.00

-8.00 (-1.16%)

13 Jan 2025 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
International Biotechnology Trust Plc	LSE:IBT	London	Ordinary Share	GB0004559349	ORD 25P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-8.00	-1.16%	684.00	684.00	686.00	690.00	684.00	690.00	129,499	16:29:11

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
Trust,ex Ed,religious,charty	12.06M	6.81M	0.1886	36.27	249.94M

Investment in Eyetech

18/11/2003 10:13am

UK Regulatory

RNS Number:1811S
Intl. Biotechnology Trust PLC
18 November 2003


                                                                18 November 2003

                             Investment in Eyetech

International Biotechnology Trust plc ("IBT") announces that Eyetech
Pharmaceuticals Inc ("Eyetech") updated its S1 Registration statement on
November 14 2003 with the US Securities and Exchange. In this filing, Eyetech
analysed the results from the first year of the Phase 2/3 pivotal clinical
trials for the use of Macugen in the treatment of wet AMD (age-related macular
degeneration). At 31 August 2003, Eyetech represented 5.86% of IBT's NAV and was
valued at #3.1m.


For further information please contact:


Kate Bingham                                        Tel: 020 7421 7068

Schroder Ventures Life Sciences Advisers (UK) Limited

John Spedding                                        Tel: 020 7658 3206

Schroder Investment Management Limited


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCUWARROARAAAA